跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KLH/SUBUNIT
首页
药物
KLH/SUBUNIT
KLH/SUBUNIT
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TNF-alpha (tumor necrosis factor-alpha) mutant protein and KLH (keyhole limpet hemocyanin), CTB (cholera toxin B subunit), OVA (ovalbumin) and BSA (bovine serum albumin) chemically coupled product and preparation method thereof
申请人: SHANGHAI HYCHARM INC
优先权: 2016
CN
Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
申请人: OBI PHARMA INC
优先权: 2014
US
IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
申请人: OBI PHARMA INC
优先权: 2014
CN
Immune response effect generated after mouse immunization of echinococcosis-resistant recombinant vaccine P29 epitope peptide
申请人: UNIV NINGXIA MEDICAL
优先权: 2022
CN
Immunogenic/therapeutic glycan compositions and uses thereof
申请人: OBI PHARMA INC
优先权: 2016
CN
US
2 件公开
药物
反馈